34.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALKS Giù?
Forum
Previsione
Frazionamento azionario
Alkermes Plc Borsa (ALKS) Ultime notizie
Alkermes Starts Phase 3 Program for Narcolepsy Drug Candidate Alixorexton - Sleep Review
Craig Hopkinson Sells 9,000 Shares of Alkermes (NASDAQ:ALKS) Stock - MarketBeat
ALKS Stock Price, Quote & Chart | ALKERMES PLC (NASDAQ:ALKS) - ChartMill
Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia - msn.com
Top 2 Health Care Stocks That May Implode In April - Sahm
Alkermes launches phase 3 trials for narcolepsy drug alixorexton By Investing.com - Investing.com Australia
Alkermes stock hits 52-week high at $36.46 By Investing.com - Investing.com Canada
Alkermes (ALKS) Advances Alixorexton into Phase 3 Trials for Nar - GuruFocus
Alkermes (NASDAQ:ALKS) Sets New 1-Year HighStill a Buy? - MarketBeat
Alkermes stock hits 52-week high at $36.46 - Investing.com
Lilly’s $7.8 Billion Bet Takes It Beyond Obesity Into Sleep - Bloomberg.com
Alkermes launches phase 3 trials for narcolepsy drug alixorexton - Investing.com
Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 - Yahoo Finance
Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market Interest - Insider Monkey
10 Stocks Dominating Today’s Market Surge: ImmunityBio, Alkermes, and More - Insider Monkey
Highs Report: What is the target price for Alkermes plc stockEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy - BioWorld MedTech
Alkermes Shares Surge 15% Following Lilly-Centessa Deal - intellectia.ai
Alkermes’ Future: Critical Developments and Financial Outlook - timothysykes.com
Alkermes (ALKS) Shares Surge by Nearly 18% in Market Rally - GuruFocus
Alkermes PLC (ALKS) Shares Up 18.16% on Mar 31 - GuruFocus
Alkermes (NASDAQ:ALKS) Shares Gap UpStill a Buy? - MarketBeat
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving High - Benzinga
Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Insider Sell: Does Alkermes plc offer margin of safety2026 Retail & Trade Opportunity Analysis Reports - baoquankhu1.vn
Bank Watch: Can Alkermes plc deliver consistent dividends2026 Big Picture & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Tudor Investment Corp ET AL Acquires New Position in Alkermes plc $ALKS - MarketBeat
Trading Systems Reacting to (ALKS) Volatility - Stock Traders Daily
Alkermes plc (NASDAQ: ALKS) AGM May 20, 2026 — CEO succession, proxy votes - Stock Titan
Why Is Alkermes (ALKS) Down 2.6% Since Last Earnings Report? - Yahoo Finance
Vanguard realignment; no Alkermes (NASDAQ: ALKS) shares reported - Stock Titan
Alkermes (NASDAQ:ALKS) Stock Rating Upgraded by Truist Financial - MarketBeat
US Stocks Recap: What is the target price for Alkermes plc stock2026 Closing Moves & Growth Focused Stock Reports - baoquankhu1.vn
Alkermes PLC (ALKS) Trading 3.57% Higher on Mar 25 - GuruFocus
Alkermes (ALKS): Piper Sandler Lowers Price Target, Maintains Ov - GuruFocus
Piper Sandler Issues Pessimistic Forecast for Alkermes (NASDAQ:ALKS) Stock Price - MarketBeat
Alkermes announces inaugural Alkermes Pathways APN Research Awards™ program - msn.com
Alkermes plc stock launches inaugural research awards program amid biotech innovation push - AD HOC NEWS
If You Invested $1,000 in Alkermes Plc (ALKS) - Stock Titan
Alkermes shares rise after revenue beat and upbeat outlook offsets earnings miss - MSN
Big Picture: Can Alkermes plc stock outperform in a bear marketMarket Movers & Expert Approved Trade Ideas - baoquankhu1.vn
Alkermes Q4 2025 earnings preview - MSN
Alkermes outlines $1.73B–$1.84B 2026 revenue target as Avadel acquisition expands commercial reach - MSN
Alkermes plc (ALKS) Latest Stock News & Headlines - Yahoo Finance
Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch - MarketBeat
Layoff Watch: Does Alkermes plc offer margin of safety2026 Volatility Report & Consistent Growth Equity Picks - baoquankhu1.vn
Holocene Advisors LP Cuts Holdings in Alkermes plc $ALKS - MarketBeat
Alkermes appoints new CFO - MSN
How Alkermes Plc (ALKS) Affects Rotational Strategy Timing - Stock Traders Daily
Farallon Capital Management LLC Has $624,000 Stock Holdings in Alkermes plc $ALKS - MarketBeat
Alkermes plc Stock (ISIN: IE00B56GVS15) Under Pressure After Avadel Acquisition—Wells Fargo Raises - AD HOC NEWS
Alkermes plc $ALKS is Commodore Capital LP's 7th Largest Position - MarketBeat
Baker BROS. Advisors LP Boosts Holdings in Alkermes plc $ALKS - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):